Autologe Stammzelltransplantation beim multiplen Myelom – contra

Schlüsselwörter

multiples Myelom - autologe Stammzelltransplantation - Hochdosischemotherapie

Keywords

multiple myeloma - autologous blood stem cell transplantation - high-dose chemotherapy

Literatur

• 1 Koreth J, Cutler C S, Djulbegovic B. et al . High-dose therapy with single autologous transplantation versus chemotherapy for newly diagnosed multiple myeloma.  Biol Blood Marrow Transplant. 2007;  13 183-196
• 2 Kumar A, Kharfan-Dabaja M A, Glasmacher A, Djulbegovic B. Tandem versus single autologous hematopoietic cell transplantation for the treatment of multiple myeloma.  J Nat Cancer Inst. 2009;  101 100-106
• 3 Ladetto M, Pagliano G, Ferrero S. et al . Major shrinking of residual tumor cell burden and achievement of molecular remissions in myeloma patients undergoing post-transplant consolidation with bortezomib, thalidomide and dexamethasone.  Blood. 2008;  112 3683
• 4 Rajkumar S V, Jacobus S, Callander N. et al . A randomized trial of lenalidomide plus high-dose dexamethasone (RD) versus lenalidomide plus low-dose dexamethasone (Rd) in newly diagnosed multiple myeloma (E4A03): A Trial Coordinated by the Eastern Cooperative Oncology Group.  Blood. 2007;  110 74